Completed OBSERVATIONAL NCT04220359

Early Identification of Clinical Deterioration Using a Wearable Monitoring Device

Early Identification of Hospitalized Patients at High-risk for Clinical Deterioration During the First 72-hours in an Internal Medicine Department. A Prospective, Continuous, Physiologic Big-data-analysis Study

Sponsor: Biobeat Technologies Ltd.

Conditions Clinical Deterioration Hemodynamic Instability

Interventions non-invasive monitoring

Updated 6 times since 2020 Last updated: May 23, 2021 Started: Jul 6, 2020 Primary completion: Apr 15, 2021 Completion: Apr 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Clinical Deterioration and Hemodynamic Instability, this trial is completed. The trial is conducted by Biobeat Technologies Ltd. and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Jun 2021 [monthly]

Recruiting
Aug 2020 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Feb 2020 — Aug 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biobeat Technologies Ltd.
Sheba Medical Center

Data source: Biobeat Technologies Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ramat Gan, Israel